FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
14 letters match. Newest first.
-
DevicesNext Medical Products Company, LLC
FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.
High risk -
DevicesPro-Optics, LLC
FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.
Medium -
BiologicsTides Medical LLC
FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.
High risk -
DevicesO.N. Diagnostics, LLC
FDA says O.N. Diagnostics sold changed VirtuOst VFA software without required clearance and had quality and reporting failures.
High risk -
DevicesAdvance-Esthetic LLC
FDA says Advance-Esthetic markets three Zemits body-contouring devices without the required FDA clearance or approval.
Medium -
DevicesNihon Kohden Digital Health Solutions, LLC
FDA says Nihon Kohden Digital Health Solutions sold an uncleared monitor software change that can silence life-threatening alarms.
High risk -
DevicesSkytron, LLC
Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.
High risk -
DevicesAseptiKits, LLC
AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.
High risk -
DevicesBMC Medical Co., Ltd.
BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.
High risk -
DevicesHappiest Baby, Inc.
FDA says Happiest Baby marketed unapproved SNOO sleep sacks and hospital bundle and mishandled complaints.
High risk -
BiologicsEstar Technologies Ltd
FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.
High risk -
DevicesExThera Medical Corporation
ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.
High risk -
BiologicsGermaphobix
FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.
High risk -
BiologicsGenetrace
FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.
High risk